These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6121307)

  • 1. Normal cerebrospinal fluid and brain glutamate levels in schizophrenia do not support the hypothesis of glutamatergic neuronal dysfunction.
    Perry TL
    Neurosci Lett; 1982 Jan; 28(1):81-5. PubMed ID: 6121307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of cerebrospinal fluid glutamic acid in Huntington's chorea and in schizophrenic patients.
    Kim JS; Kornhuber HH; Holzmüller B; Schmid-Burgk W; Mergner T; Krzepinski G
    Arch Psychiatr Nervenkr (1970); 1980; 228(1):7-10. PubMed ID: 6104477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid amino acid concentrations in chronic schizophrenia.
    Korpi ER; Kaufmann CA; Marnela KM; Weinberger DR
    Psychiatry Res; 1987 Apr; 20(4):337-45. PubMed ID: 2885877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral glutamate, neuroleptic drugs and schizophrenia: increase of cerebrospinal fluid glutamate levels and decrease of striate body glutamate levels following sulpiride treatment in rats.
    Kim JS; Claus D; Kornhuber HH
    Eur Neurol; 1983; 22(5):367-70. PubMed ID: 6138256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia.
    Kim JS; Kornhuber HH; Schmid-Burgk W; Holzmüller B
    Neurosci Lett; 1980 Dec; 20(3):379-82. PubMed ID: 6108541
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of chronic amphetamine treatment on the glutamate concentration in cerebrospinal fluid and brain: implications for a theory of schizophrenia.
    Kim JS; Kornhuber HH; Brand U; Menge HG
    Neurosci Lett; 1981 Jun; 24(1):93-6. PubMed ID: 6115345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A biochemical theory of schizophrenia].
    Kornhuber HH; Kornhuber J; Kim JS; Kornhuber ME
    Nervenarzt; 1984 Nov; 55(11):602-6. PubMed ID: 6151120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quantitative analysis of gamma-aminobutyric acid and glutamic acid in the cerebrospinal fluid of schizophrenics].
    Shen QJ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 May; 15(2):98-103. PubMed ID: 6127192
    [No Abstract]   [Full Text] [Related]  

  • 9. Glutamate in schizophrenics and healthy controls.
    Gattaz WF; Gattaz D; Beckmann H
    Arch Psychiatr Nervenkr (1970); 1982; 231(3):221-5. PubMed ID: 6123303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients.
    Hashimoto K; Engberg G; Shimizu E; Nordin C; Lindström LH; Iyo M
    BMC Psychiatry; 2005 Jan; 5():6. PubMed ID: 15683541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain metabolite abnormalities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction.
    Chang L; Friedman J; Ernst T; Zhong K; Tsopelas ND; Davis K
    Biol Psychiatry; 2007 Dec; 62(12):1396-404. PubMed ID: 17693392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid levels of quinolinic acid in Huntington's disease and schizophrenia.
    Schwarcz R; Tamminga CA; Kurlan R; Shoulson I
    Ann Neurol; 1988 Oct; 24(4):580-2. PubMed ID: 2977086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuronal pathology of schizophrenia: molecules and mechanisms.
    Reynolds GP; Harte MK
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):433-6. PubMed ID: 17371293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia.
    Erhardt S; Blennow K; Nordin C; Skogh E; Lindström LH; Engberg G
    Neurosci Lett; 2001 Nov; 313(1-2):96-8. PubMed ID: 11684348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of reliability and biological significance of glutamate levels in cerebrospinal fluid.
    Ferrarese C; Pecora N; Frigo M; Appollonio I; Frattola L
    Ann Neurol; 1993 Mar; 33(3):316-9. PubMed ID: 8098930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation of the effects of intracerebral injection in the marmoset of cytopathic cerebrospinal fluid from patients with schizophrenia or neurological disease.
    Baker HF; Ridley RM; Crow TJ; Bloxham CA; Parry RP; Tyrrell DA
    Psychol Med; 1983 Aug; 13(3):499-511. PubMed ID: 6226054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of glutamate and of free fatty acids in vasogenic brain edema.
    Baethmann A; Maier-Hauff K; Schürer L; Lange M; Guggenbichler C; Vogt W; Jacob K; Kempski O
    J Neurosurg; 1989 Apr; 70(4):578-91. PubMed ID: 2564431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid acetylcholinesterase in neuropsychiatric disorders.
    Davis KL; Hollister LE; Livesey J; Berger PA
    Psychopharmacology (Berl); 1979 May; 63(2):155-9. PubMed ID: 157494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further studies of elevated cerebrospinal fluid neuronal cell adhesion molecule in schizophrenia.
    van Kammen DP; Poltorak M; Kelley ME; Yao JK; Gurklis JA; Peters JL; Hemperly JJ; Wright RD; Freed WJ
    Biol Psychiatry; 1998 May; 43(9):680-6. PubMed ID: 9583002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia.
    Bendikov I; Nadri C; Amar S; Panizzutti R; De Miranda J; Wolosker H; Agam G
    Schizophr Res; 2007 Feb; 90(1-3):41-51. PubMed ID: 17156977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.